產(chǎn)品詳情
簡單介紹：
Anti-IGF2BP1抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-IGF2BP1抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-IGF2BP1
Cat. Number:
Anti-IGF2BP1抗體KL-8683R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
IGF-II mRNA-binding proteins (IMP) bind RNA and influence RNA synthesis and metabolism. IMPs, IMP-1 (coding region determinant-binding protein/insulin-like growth factor II mRNA-binding protein, CRD-BP, VICKZ1), IMP-2 (IMP2, VICKZ2, p62) and IMP-3 (KOC1, VICKZ3), contain a unique combination of RNA recognition Anti-IGF2BP1抗體motifs and four hnRNP K homology domains. IMP-1 is abundant in embryonal tissues and in 81% of colon cancers, 58.5% of breast cancers and 73% of sarcomas. IMP-1 recognizes c-Myc, IGF-II and tau mRNAs, and H19 RNA and plays a major role in proliferation of K-562 cells by an IGF-II-dependent mechanism. IMP-2 binds the 5' UTR of IGF-II mRNA and influences tumor cell growth, in which IMP-2 is associated with apoptosis induced by tretinoin. IMP-3 knock down by RNA interference decreases levels of IGF-II protein without affecting IGF-II, c-Myc, or b Actin mRNA and H19 RNA levels. IMP-3 is a marker for carcinomas and high-grade dysplastic lesions of pancreatic ductal epithelium.
Also known as:
CRD BP; Coding region determinant-binding protein; CRD-BP; CRDBP; IF2B1; IF2B1_HUMAN; IGF II mRNA binding protein 1; IGF-II mRNA-binding protein 1; IGF2 mRNA binding protein 1; IGF2 mRNA-binding protein 1; IGF2BP1; Anti-IGF2BP1抗體IMP 1; IMP-1; IMP1; Insulin like growth factor 2 mRNA binding protein 1; Insulin-like growth factor 2 mRNA-binding protein 1; VICKZ family member 1; VICKZ1; ZBP 1; ZBP-1; ZBP1; Zip code binding protein 1; Zip code-binding protein 1; Zipcode binding protein 1; Zipcode-binding protein 1.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Zebrafish, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human IGF2BP1/.
●
Predicted Molecular Weight: 63kDa.Anti-IGF2BP1抗體
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-IGF2BP1抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-IGF2BP1抗體
Optimal working dilutions must be determined by the end user.
kl213Hu01 髓細胞觸發(fā)受體1(TREM1)多克隆抗體 Polyclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)
kl213Mu01 髓細胞觸發(fā)受體1(TREM1)多克隆抗體 Polyclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)
kl213Po01 髓細胞觸發(fā)受體1(TREM1)多克隆抗體 Polyclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)
kl213Ra01 髓細胞觸發(fā)受體1(TREM1)多克隆抗體 Polyclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)
kl214Bo01 窖蛋白(CAV1)多克隆抗體 Polyclonal Antibody to Caveolin 1 (CAV1)
kl214Ca01 窖蛋白(CAV1)多克隆抗體 Polyclonal Antibody to Caveolin 1 (CAV1)
kl214Cp01 窖蛋白(CAV1)多克隆抗體 Polyclonal Antibody to Caveolin 1 (CAV1)
kl214Eq01 窖蛋白(CAV1)多克隆抗體 Polyclonal Antibody to Caveolin 1 (CAV1)
kl214Ga01 窖蛋白(CAV1)多克隆抗體 Polyclonal Antibody to Caveolin 1 (CAV1)
kl214Hu01 窖蛋白(CAV1)多克隆抗體 Polyclonal Antibody to Caveolin 1 (CAV1)
kl214Mu01 窖蛋白(CAV1)多克隆抗體 Polyclonal Antibody to Caveolin 1 (CAV1)
kl214Po01 窖蛋白(CAV1)多克隆抗體 Polyclonal Antibody to Caveolin 1 (CAV1)
kl214Ra01 窖蛋白(CAV1)多克隆抗體 Polyclonal Antibody to Caveolin 1 (CAV1)
kl214Rb51 窖蛋白(CAV1)多克隆抗體 Polyclonal Antibody to Caveolin 1 (CAV1)
kl214Si01 窖蛋白(CAV1)多克隆抗體 Polyclonal Antibody to Caveolin 1 (CAV1)
kl215Bo01 Ⅰ型膠原α2(COL1α2)多克隆抗體 Polyclonal Antibody to Collagen Type I Alpha 2 (COL1a2)
kl215Ca01 Ⅰ型膠原α2(COL1α2)多克隆抗體 Polyclonal Antibody to Collagen Type I Alpha 2 (COL1a2)
kl215Ga01 Ⅰ型膠原α2(COL1α2)多克隆抗體 Polyclonal Antibody to Collagen Type I Alpha 2 (COL1a2)
